Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine.

LaForce FM, Okwo-Bele JM.

Health Aff (Millwood). 2011 Jun;30(6):1049-57. doi: 10.1377/hlthaff.2011.0328.

2.

Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa.

Bishai DM, Champion C, Steele ME, Thompson L.

Health Aff (Millwood). 2011 Jun;30(6):1058-64. doi: 10.1377/hlthaff.2011.0295.

3.

Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.

Miller MA, Wenger J, Rosenstein N, Perkins B.

Pediatr Infect Dis J. 1999 Dec;18(12):1051-9.

PMID:
10608623
4.

Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Dec 21;61(50):1025-8.

5.

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.

Okoko BJ, Idoko OT, Adegbola RA.

Vaccine. 2009 Mar 23;27(14):2023-9. doi: 10.1016/j.vaccine.2008.11.092. Epub 2008 Dec 16. Review.

PMID:
19095025
6.

Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.

Vogel G.

Science. 2003 Mar 7;299(5612):1499-501. No abstract available.

PMID:
12624241
7.

Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.

Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D, Lingani C, Preziosi MP, Zuber PL, Perea W, Hugonnet S, Dellepiane de Rey Tolve N, Tevi-Benissan C, Clark TA, Mayer LW, Novak R, Messonier NE, Berlier M, Toboe D, Nshimirimana D, Mihigo R, Aguado T, Diomandé F, Kristiansen PA, Caugant DA, Laforce FM.

Vaccine. 2012 May 30;30 Suppl 2:B40-5. doi: 10.1016/j.vaccine.2011.12.073. Review.

PMID:
22607898
8.

From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.

Aguado MT, Jodar L, Granoff D, Rabinovich R, Ceccarini C, Perkin GW.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S391-5. doi: 10.1093/cid/civ593. Review.

9.

Neisseria meningitidis serogroup A vaccines: an overview.

Vergnano S, Heath P.

Expert Rev Vaccines. 2003 Aug;2(4):571-82. Review.

PMID:
14711341
10.

[Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].

da Silva A, Parent du Châtelet I, Beckr Gaye A, Dompnier JP, Seck I.

Sante. 2003 Oct-Dec;13(4):215-23. French.

11.

[Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].

du Châtelet IP, Alonso JM, Taha MK.

Bull Soc Pathol Exot. 2002 Dec;95(5):323-4; discussion 324-5. Review. French.

PMID:
12696368
12.

Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Dec 21;61(50):1022-4.

13.

Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.

Meyer SA, Kambou JL, Cohn A, Goodson JL, Flannery B, Medah I, Messonnier N, Novak R, Diomande F, Djingarey MH, Clark TA, Yameogo I, Fall A, Wannemuehler K.

Vaccine. 2015 Mar 17;33(12):1492-8. doi: 10.1016/j.vaccine.2015.01.043. Epub 2015 Jan 28.

PMID:
25636915
14.

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.

Marc LaForce F, Ravenscroft N, Djingarey M, Viviani S.

Vaccine. 2009 Jun 24;27 Suppl 2:B13-9. doi: 10.1016/j.vaccine.2009.04.062. Epub 2009 May 27. Review.

PMID:
19477559
15.

Meningococcal vaccine in travelers.

Wilder-Smith A.

Curr Opin Infect Dis. 2007 Oct;20(5):454-60. Review.

PMID:
17762777
16.

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.

Mueller JE, Borrow R, Gessner BD.

Expert Rev Vaccines. 2006 Jun;5(3):319-36. Review.

PMID:
16827617
17.

Vaccine introduction. The beginning of the end for Africa's devastating meningitis outbreaks?

Roberts L.

Science. 2010 Dec 10;330(6010):1466-7. doi: 10.1126/science.330.6010.1466. No abstract available.

PMID:
21148362
18.

Meningitis epidemics in Africa: a brief overview.

Teyssou R, Muros-Le Rouzic E.

Vaccine. 2007 Sep 3;25 Suppl 1:A3-7. Epub 2007 May 15. Review.

PMID:
17643560
19.

The Meningitis Vaccine Project.

LaForce FM, Konde K, Viviani S, Préziosi MP.

Vaccine. 2007 Sep 3;25 Suppl 1:A97-100. Epub 2007 May 7.

PMID:
17521780
20.

Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.

Cibrelus L, Medah I, Koussoubé D, Yélbeogo D, Fernandez K, Lingani C, Djingarey M, Hugonnet S.

Emerg Infect Dis. 2015 Nov;21(11):2063-6. doi: 10.3201/eid2111.150304.

Supplemental Content

Support Center